Of note, KLRG1 expression has been found to positively correlate with the efficacy of ICIs, demonstrating that, besides its negative role, KLRG1 may behave as a predictive biomarker of immunotherapy clinical benefit in lung adenocarcinoma [258]. Here, KLRG1 is linked to lung adenocarcinoma.